Spectral Medical Inc. (TSX:EDT)
1.370
+0.030 (2.24%)
Jun 11, 2026, 3:59 PM EST
Spectral Medical Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Spectral Medical stock has a consensus rating of "Strong Buy" and an average price target of $3.15. The average 1-year stock price forecast is 129.93% higher than the current stock price, while the lowest is $2.80 (+104.38%) and the highest is $3.50 (+155.47%).
Price Target: $3.15 (+129.93%)
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Spectral Medical stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 2 | 2 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Research Capital | Research Capital | Buy Maintains $3.50 | Buy | Maintains | $3.50 | +155.47% | May 31, 2026 |
Financial Forecast
Revenue This Year
2.81M
from 2.44M
Increased by 14.95%
Revenue Next Year
18.70M
from 2.81M
Increased by 566.16%
EPS This Year
-0.03
EPS Next Year
n/a
from -0.03
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CAD.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 2.8M | ||
| Avg | 2.8M | ||
| Low | 2.8M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 14.9% | ||
| Avg | 14.9% | ||
| Low | 14.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -0.03 | ||
| Avg | -0.03 | ||
| Low | -0.03 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | ||
| Avg | - | ||
| Low | - |